40.82 USD
-0.88 (-2.11%)
40.82 USD
0 (0%)
We assign a fundamental rating of 7 out of 10 to AMEH. AMEH was compared to 101 industry peers in the Health Care Providers & Services industry. AMEH has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. AMEH is not priced too expensively while it is growing strongly. Keep and eye on this one! This makes AMEH very considerable for growth and quality investing!
1. Profitability
1.1 Basic Checks
In the past year AMEH was profitable.
In the past year AMEH had a positive cash flow from operations.
AMEH had positive earnings in each of the past 5 years.
AMEH had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of 4.27%, AMEH is doing good in the industry, outperforming 74.58% of the companies in the same industry.
The Return On Equity of AMEH (7.71%) is better than 71.19% of its industry peers.
AMEH has a Return On Invested Capital of 7.06%. This is in the better half of the industry: AMEH outperforms 75.42% of its industry peers.
AMEH had an Average Return On Invested Capital over the past 3 years of 7.61%. This is in line with the industry average of 9.27%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.27% | ||
| ROE | 7.71% | ||
| ROIC | 7.06% |
ROA(3y)6.13%
ROA(5y)4.48%
ROE(3y)12.25%
ROE(5y)10.02%
ROIC(3y)7.61%
ROIC(5y)7.78%
1.3 Margins
The Profit Margin of AMEH (3.45%) is better than 75.42% of its industry peers.
AMEH's Profit Margin has improved in the last couple of years.
The Operating Margin of AMEH (7.61%) is better than 77.97% of its industry peers.
AMEH's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 16.34%, AMEH is doing worse than 70.34% of the companies in the same industry.
In the last couple of years the Gross Margin of AMEH has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.61% | ||
| PM (TTM) | 3.45% | ||
| GM | 16.34% |
OM growth 3Y14.1%
OM growth 5YN/A
PM growth 3Y19.41%
PM growth 5YN/A
GM growth 3Y1.75%
GM growth 5Y2.84%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AMEH is destroying value.
AMEH has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, AMEH has an improved debt to assets ratio.
2.2 Solvency
AMEH has an Altman-Z score of 4.53. This indicates that AMEH is financially healthy and has little risk of bankruptcy at the moment.
AMEH has a better Altman-Z score (4.53) than 83.90% of its industry peers.
The Debt to FCF ratio of AMEH is 1.89, which is an excellent value as it means it would take AMEH, only 1.89 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of AMEH (1.89) is better than 85.59% of its industry peers.
A Debt/Equity ratio of 0.35 indicates that AMEH is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.35, AMEH is in the better half of the industry, outperforming 65.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.35 | ||
| Debt/FCF | 1.89 | ||
| Altman-Z | 4.53 |
ROIC/WACC0.85
WACC8.27%
2.3 Liquidity
A Current Ratio of 2.35 indicates that AMEH has no problem at all paying its short term obligations.
AMEH has a better Current ratio (2.35) than 79.66% of its industry peers.
A Quick Ratio of 2.35 indicates that AMEH has no problem at all paying its short term obligations.
AMEH has a better Quick ratio (2.35) than 81.36% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.35 | ||
| Quick Ratio | 2.35 |
3. Growth
3.1 Past
The earnings per share for AMEH have decreased strongly by -29.58% in the last year.
The Earnings Per Share has been growing by 42.03% on average over the past years. This is a very strong growth
The Revenue has grown by 27.05% in the past year. This is a very strong growth!
Measured over the past years, AMEH shows a very strong growth in Revenue. The Revenue has been growing by 81.94% on average per year.
EPS 1Y (TTM)-29.58%
EPS 3Y42.03%
EPS 5YN/A
EPS Q2Q%-16.07%
Revenue 1Y (TTM)27.05%
Revenue growth 3Y26.85%
Revenue growth 5Y81.94%
Sales Q2Q%9.84%
3.2 Future
Based on estimates for the next years, AMEH will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.59% on average per year.
Based on estimates for the next years, AMEH will show a very strong growth in Revenue. The Revenue will grow by 26.59% on average per year.
EPS Next Y15.47%
EPS Next 2Y16.56%
EPS Next 3Y15.59%
EPS Next 5YN/A
Revenue Next Year25.04%
Revenue Next 2Y26.5%
Revenue Next 3Y26.59%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 40.82, the valuation of AMEH can be described as expensive.
Based on the Price/Earnings ratio, AMEH is valued a bit cheaper than the industry average as 60.17% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 25.98, AMEH is valued quite expensively.
AMEH is valuated quite expensively with a Price/Forward Earnings ratio of 28.34.
62.71% of the companies in the same industry are more expensive than AMEH, based on the Price/Forward Earnings ratio.
AMEH's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 35.79.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.82 | ||
| Fwd PE | 28.34 |
4.2 Price Multiples
AMEH's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. AMEH is cheaper than 61.86% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, AMEH is valued a bit cheaper than the industry average as 73.73% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.06 | ||
| EV/EBITDA | 15.55 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AMEH does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of AMEH may justify a higher PE ratio.
AMEH's earnings are expected to grow with 15.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.64
PEG (5Y)N/A
EPS Next 2Y16.56%
EPS Next 3Y15.59%
5. Dividend
5.1 Amount
No dividends for AMEH!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
40.82
-0.88 (-2.11%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners53.14%
Inst Owner Change3.3%
Ins Owners21.32%
Ins Owner Change0%
Market Cap1.90B
Revenue(TTM)1.33B
Net Income(TTM)45.80M
Analysts83.33
Price Target47.49 (16.34%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.31
Dividend Growth(5Y)N/A
DP7.9%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.72%
Min EPS beat(2)9.8%
Max EPS beat(2)39.63%
EPS beat(4)3
Avg EPS beat(4)20.8%
Min EPS beat(4)-0.9%
Max EPS beat(4)39.63%
EPS beat(8)6
Avg EPS beat(8)22.78%
EPS beat(12)10
Avg EPS beat(12)32.72%
EPS beat(16)12
Avg EPS beat(16)-118.74%
Revenue beat(2)0
Avg Revenue beat(2)-1.33%
Min Revenue beat(2)-2.49%
Max Revenue beat(2)-0.17%
Revenue beat(4)2
Avg Revenue beat(4)4.65%
Min Revenue beat(4)-2.49%
Max Revenue beat(4)17.32%
Revenue beat(8)6
Avg Revenue beat(8)8.34%
Revenue beat(12)10
Avg Revenue beat(12)8.2%
Revenue beat(16)12
Avg Revenue beat(16)7.16%
PT rev (1m)4.22%
PT rev (3m)-6.25%
EPS NQ rev (1m)-0.44%
EPS NQ rev (3m)7.6%
EPS NY rev (1m)0%
EPS NY rev (3m)-7.34%
Revenue NQ rev (1m)-0.14%
Revenue NQ rev (3m)0.91%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.27%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 40.82 | ||
| Fwd PE | 28.34 | ||
| P/S | 1.43 | ||
| P/FCF | 17.06 | ||
| P/OCF | 14.21 | ||
| P/B | 3.2 | ||
| P/tB | 7.79 | ||
| EV/EBITDA | 15.55 |
EPS(TTM)1
EY2.45%
EPS(NY)1.44
Fwd EY3.53%
FCF(TTM)2.39
FCFY5.86%
OCF(TTM)2.87
OCFY7.04%
SpS28.49
BVpS12.74
TBVpS5.24
PEG (NY)2.64
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.27% | ||
| ROE | 7.71% | ||
| ROCE | 11.61% | ||
| ROIC | 7.06% | ||
| ROICexc | 10.35% | ||
| ROICexgc | 25.21% | ||
| OM | 7.61% | ||
| PM (TTM) | 3.45% | ||
| GM | 16.34% | ||
| FCFM | 8.4% |
ROA(3y)6.13%
ROA(5y)4.48%
ROE(3y)12.25%
ROE(5y)10.02%
ROIC(3y)7.61%
ROIC(5y)7.78%
ROICexc(3y)12.15%
ROICexc(5y)11.69%
ROICexgc(3y)43.38%
ROICexgc(5y)51.37%
ROCE(3y)12.51%
ROCE(5y)12.79%
ROICexgc growth 3Y1.89%
ROICexgc growth 5YN/A
ROICexc growth 3Y32.67%
ROICexc growth 5YN/A
OM growth 3Y14.1%
OM growth 5YN/A
PM growth 3Y19.41%
PM growth 5YN/A
GM growth 3Y1.75%
GM growth 5Y2.84%
F-Score6
Asset Turnover1.24
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.35 | ||
| Debt/FCF | 1.89 | ||
| Debt/EBITDA | 1.76 | ||
| Cap/Depr | 132.23% | ||
| Cap/Sales | 1.68% | ||
| Interest Coverage | 8.45 | ||
| Cash Conversion | 113.54% | ||
| Profit Quality | 243.47% | ||
| Current Ratio | 2.35 | ||
| Quick Ratio | 2.35 | ||
| Altman-Z | 4.53 |
F-Score6
WACC8.27%
ROIC/WACC0.85
Cap/Depr(3y)82.27%
Cap/Depr(5y)51.68%
Cap/Sales(3y)1.55%
Cap/Sales(5y)1.01%
Profit Quality(3y)102.9%
Profit Quality(5y)124.71%
High Growth Momentum
Growth
EPS 1Y (TTM)-29.58%
EPS 3Y42.03%
EPS 5YN/A
EPS Q2Q%-16.07%
EPS Next Y15.47%
EPS Next 2Y16.56%
EPS Next 3Y15.59%
EPS Next 5YN/A
Revenue 1Y (TTM)27.05%
Revenue growth 3Y26.85%
Revenue growth 5Y81.94%
Sales Q2Q%9.84%
Revenue Next Year25.04%
Revenue Next 2Y26.5%
Revenue Next 3Y26.59%
Revenue Next 5YN/A
EBIT growth 1Y7.56%
EBIT growth 3Y44.74%
EBIT growth 5YN/A
EBIT Next Year55.45%
EBIT Next 3Y28.75%
EBIT Next 5YN/A
FCF growth 1Y77.28%
FCF growth 3Y67.35%
FCF growth 5YN/A
OCF growth 1Y67.48%
OCF growth 3Y81.79%
OCF growth 5YN/A
APOLLO MEDICAL HOLDINGS INC / AMEH FAQ
Can you provide the ChartMill fundamental rating for APOLLO MEDICAL HOLDINGS INC?
ChartMill assigns a fundamental rating of 6 / 10 to AMEH.
What is the valuation status for AMEH stock?
ChartMill assigns a valuation rating of 3 / 10 to APOLLO MEDICAL HOLDINGS INC (AMEH). This can be considered as Overvalued.
What is the profitability of AMEH stock?
APOLLO MEDICAL HOLDINGS INC (AMEH) has a profitability rating of 7 / 10.
Can you provide the financial health for AMEH stock?
The financial health rating of APOLLO MEDICAL HOLDINGS INC (AMEH) is 8 / 10.
What is the expected EPS growth for APOLLO MEDICAL HOLDINGS INC (AMEH) stock?
The Earnings per Share (EPS) of APOLLO MEDICAL HOLDINGS INC (AMEH) is expected to grow by 15.47% in the next year.